154 related articles for article (PubMed ID: 15807176)
1. Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients.
Hodkova M; Dusilova-Sulkova S; Skalicka A; Kalousova M; Zima T; Bartunkova J
Ren Fail; 2005; 27(2):135-41. PubMed ID: 15807176
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
Eiselt J; Racek J; Opatrný K; Trefil L; Stehlík P
Blood Purif; 2006; 24(5-6):531-7. PubMed ID: 17077626
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
[TBL] [Abstract][Full Text] [Related]
4. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
5. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
Baldi S; Innocenti M; Frascerra S; Nannipieri M; Lippi A; Rindi P; Ferrannini E
J Nephrol; 2013; 26(3):549-55. PubMed ID: 22941872
[TBL] [Abstract][Full Text] [Related]
6. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
[TBL] [Abstract][Full Text] [Related]
7. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
8. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.
Anraku M; Kitamura K; Shinohara A; Adachi M; Suenga A; Maruyama T; Miyanaka K; Miyoshi T; Shiraishi N; Nonoguchi H; Otagiri M; Tomita K
Kidney Int; 2004 Aug; 66(2):841-8. PubMed ID: 15253741
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron gluconate administration increases circulating PAPP-A in hemodialysis patients.
Hodkova M; Kalousova M; Dusilova-Sulkova S; Malbohan IM; Zima T
Ren Fail; 2005; 27(6):707-11. PubMed ID: 16350822
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
13. Study of Protein Oxidative Stress, Antioxidant Vitamins and Inflammation in Patients Undergoing either Hemodialysis or Peritoneal Dialysis.
Marques de Mattos A; Afonso Jordão A; Abrão Cardeal da Costa J; Garcia Chiarello P
Int J Vitam Nutr Res; 2014; 84(5-6):261-8. PubMed ID: 26255547
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the iron metabolism and effectiveness of anemia treatment in patients on maintenance hemodialysis performed based on polysulfone and helixone dialyzers].
Sobaszek-Pitas M; Krzanowska K; Sułowicz W
Przegl Lek; 2014; 71(8):418-22. PubMed ID: 25546912
[TBL] [Abstract][Full Text] [Related]
16. Pomegranate juice intake attenuates the increase in oxidative stress induced by intravenous iron during hemodialysis.
Shema-Didi L; Kristal B; Ore L; Shapiro G; Geron R; Sela S
Nutr Res; 2013 Jun; 33(6):442-6. PubMed ID: 23746559
[TBL] [Abstract][Full Text] [Related]
17. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Pai AB; Conner T; McQuade CR; Olp J; Hicks P
Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
[TBL] [Abstract][Full Text] [Related]
19. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis.
Roob JM; Khoschsorur G; Tiran A; Horina JH; Holzer H; Winklhofer-Roob BM
J Am Soc Nephrol; 2000 Mar; 11(3):539-549. PubMed ID: 10703678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
